$NBIO continued to reduce its liabilities through
Post# of 23609
(Total Views: 44)
Posted On: 10/01/2020 1:12:17 PM
$NBIO continued to reduce its liabilities through stock conversion and payment of accounts payable and accrued liabilities. The reduction was achieved through the conversion of debt to equity and the reduction of liabilities, including its last convertible note. The convertible note's principal is now $11,250 down from $161,250, a reduction of $150,000.
Nascent's CEO Sean Carrick states," The reduction of debt puts Nascent in a stronger position to move forward with the clinical trials which are to begin soon. Further liability management is a primarily objective of the Company."
$HLTY $CTIC $JNJ $MRK $GILD $REGN $MRNA $PFE $ABT $CODX $NVAX $CYDY $GSK $SNY $MRK $INO $VXRT $NNVC $COCP $VIR $NBIO $HTBX $TGRO $DSCR $MMEX $NYXO $DPLS
Nascent's CEO Sean Carrick states," The reduction of debt puts Nascent in a stronger position to move forward with the clinical trials which are to begin soon. Further liability management is a primarily objective of the Company."
$HLTY $CTIC $JNJ $MRK $GILD $REGN $MRNA $PFE $ABT $CODX $NVAX $CYDY $GSK $SNY $MRK $INO $VXRT $NNVC $COCP $VIR $NBIO $HTBX $TGRO $DSCR $MMEX $NYXO $DPLS
(0)
(0)Scroll down for more posts ▼